News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Nau Jeffrey
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/04/2023 |
4
| Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns:
| Paid exercise price by delivering 2,607 shares
@ $11.7, valued at
$30.5k
Unknown transaction of 100,738 shares
@ $0 Disposed/sold 47,975 shares
@ $0 Disposed/sold 1,000 shares
@ $0 Disposed/sold 350,000 rights
@ $0 Disposed/sold 11,031 options to buy
@ $0.2, valued at
$2.2k
Disposed/sold 434,774 options to buy
@ $1.02, valued at
$443.5k
Disposed/sold 387,151 options to buy
@ $5.33, valued at
$2.1M
Disposed/sold 211,533 options to buy
@ $32.65, valued at
$6.9M
Disposed/sold 116,539 options to buy
@ $18.77, valued at
$2.2M
Disposed/sold 210,000 options to buy
@ $16, valued at
$3.4M
|
|
12/06/2022 |
4/A
| Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns:
| Paid exercise price by delivering 8,938 shares
@ $11.2, valued at
$100.1k
|
|
12/05/2022 |
4
| Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns:
| Paid exercise price by delivering 6,217 shares
@ $11.2, valued at
$69.6k
|
|
07/08/2022 |
4
| Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns:
| Granted 350,000 rights
@ $0 |
|
01/11/2022 |
4
| Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns:
| Granted 46,700 shares
@ $0 Granted 210,000 options to buy
@ $16, valued at
$3.4M
|
|
10/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/30/2020 |
4
| Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns:
| Exercised 5,000 options to buy
@ $1.02, valued at
$5.1k
|
|
02/05/2020 |
4
| Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns:
| Granted 211,533 options to buy
@ $32.65, valued at
$6.9M
|
|
11/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|